The role of osteopontin in the induction of the CD40 ligand in Graves' disease

Clinical Endocrinology

Volumn 80, Issue 1, 2014, Pages 128-134

  Qi, Yicheng ^a,b   Li, Xiaoli ^a,b   Ma, Xinran ^b,c   Xu, Lingyan ^b,c   Zhang, Xiaofang ^a   Jiang, Xiaohua ^a   Hong, Jie ^a   Cui, Bin ^a,b   Ning, Guang ^a,b   Wang, Shu ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; OSTEOPONTIN; RECOMBINANT PROTEIN;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LABORATORY TEST; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; REMISSION; SIGNAL TRANSDUCTION;

CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAVES DISEASE; HUMANS; OSTEOPONTIN; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84889586842     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12229     Document Type: Article

References (35)

1. Rapoport, B., &, McLachlan, S.M., (2001) Thyroid autoimmunity. Journal of Clinical Investigation, 108, 1253-1259.
2. DeGroot, L.J., &, Quintans, J., (1989) The causes of autoimmune thyroid disease. Endocrine Reviews, 10, 537-562.
3. Smith, B.R., Sanders, J., &, Furmaniak, J., (2007) TSH receptor antibodies. Thyroid, 17, 923-938.
4. Pozzilli, P., Carotenuto, P., &, Delitala, G., (1994) Lymphocytic traffic and homing into target tissue and the generation of endocrine autoimmunity. Clinical Endocrinology, 41, 545-554.
5. Douglas, R.S., Naik, V., Hwang, C.J., et al,. (2008) B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. Journal of Immunology, 181, 5768-5774.
6. Ueki, I., Abiru, N., Kobayashi, M., et al,. (2011) B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism. Clinical and Experimental Immunology, 163, 309-317.
7. Lund, S.A., Giachelli, C.M., &, Scatena, M., (2009) The role of osteopontin in inflammatory processes. Journal of Cell Communication and Signaling, 3, 311-322.
8. Ashkar, S., Weber, G.F., Panoutsakopoulou, V., et al,. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science, 287, 860-864.
9. Murugaiyan, G., Mittal, A., &, Weiner, H.L., (2008) Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. Journal of Immunology, 181, 7480-7488.
10. Zheng, W., Li, R., Pan, H., et al,. (2009) Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis. Arthritis and Rheumatism, 60, 1957-1965.
11. Morimoto, J., Kon, S., Matsui, Y., et al,. (2010) Osteopontin; as a target molecule for the treatment of inflammatory diseases. Current Drug Targets, 11, 494-505.
12. Xu, G., Nie, H., Li, N., et al,. (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. Journal of Clinical Investigation, 115, 1060-1067.
13. Zhao, F., Zhang, Y., Wang, H., et al,. (2011) Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease. Blood, 117, 1723-1733.
14. Xu, L., Ma, X., Wang, Y., et al,. (2011) The expression and pathophysiological role of osteopontin in Graves' disease. Journal of Clinical Endocrinology and Metabolism, 96, E1866-E1870.
15. Lampe, M.A., Patarca, R., Iregui, M.V., et al,. (1991) Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. Journal of Immunology, 147, 2902-2906.
16. Iizuka, J., Katagiri, Y., Tada, N., et al,. (1998) Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Laboratory Investigation, 78, 1523-1533.
17. Nurieva, R.I., Chung, Y., Hwang, D., et al,. (2008) Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity, 29, 138-149.
18. Neron, S., Nadeau, P.J., Darveau, A., et al,. (2011) Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation. Archivum Immunolgiae et Therapiae Experimentalis, 59, 25-40.
19. Locksley, R.M., Killeen, N., &, Lenardo, M.J., (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104, 487-501.
20. Hollenbaugh, D., Grosmaire, L.S., Kullas, C.D., et al,. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO Journal, 11, 4313-4321.
21. Hassan, G.S., Merhi, Y., &, Mourad, W.M., (2009) CD154 and its receptors in inflammatory vascular pathologies. Trends in Immunology, 30, 165-172.
22. Alaaeddine, N., Hassan, G.S., Yacoub, D., et al,. (2012) CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis. Clinical and Developmental Immunology, 2012, 490148.
23. Mehta, J., Genin, A., Brunner, M., et al,. (2010) Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis. Arthritis and Rheumatism, 62, 2499-2509.
24. Chiarelli, F., Giannini, C., Verrotti, A., et al,. (2008) Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria. Diabetes Metabolism Research and Reviews, 24, 570-576.
25. Yamamoto, K., Itoh, M., Okamura, T., et al,. (2012) Relative levels of the inflammatory cytokine TNFalpha and the soluble CD40 ligand profile in serum correlate with the thyrotoxic activity of Graves' disease. Thyroid, 22, 516-521.
26. Varo, N., Nuzzo, R., Natal, C., et al,. (2006) Influence of pre-analytical and analytical factors on soluble CD40L measurements. Clinical Science (London), 111, 341-347.
27. Edwards, K.M., Hong, S., Woods, B.G., et al,. (2007) Reduction of plasma sCD40L and stimulated MIP-1-alpha production by in vivo beta-adrenergic stimulation. NeuroImmunoModulation, 14, 266-271.
28. Grewal, I.S., &, Flavell, R.A., (1996) The role of CD40 ligand in costimulation and T-cell activation. Immunological Reviews, 153, 85-106.
29. Fountoulakis, S., &, Tsatsoulis, A., (2004) On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clinical Endocrinology, 60, 397-409.
30. Inukai, Y., Momobayashi, A., Sugawara, N., et al,. (2007) Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease. European Journal of Endocrinology, 156, 623-630.
31. Yoshida, A., Kohchi, C., Inagawa, H., et al,. (2009) Improvement of allergic dermatitis via regulation of the Th1/Th2 immune system balance by macrophages activated with lipopolysaccharide derived from Pantoea agglomerans (IP-PA1). Anticancer Research, 29, 4867-4870.
32. Ajjan, R.A., &, Weetman, A.P., (2003) Cytokines in thyroid autoimmunity. Autoimmunity, 36, 351-359.
33. Dalan, R., &, Leow, M.K., (2012) Immune manipulation for Graves' disease: re-exploring an unfulfilled promise with modern translational research. European Journal of Internal Medicine, 23, 682-691.
34. Wang, K.X., &, Denhardt, D.T., (2008) Osteopontin: role in immune regulation and stress responses. Cytokine & Growth Factor Reviews, 19, 333-345.
35. Henn, V., Slupsky, J.R., Grafe, M., et al,. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391, 591-594.